Archived information is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was ...

The agreements include $200 million in data licensing and model development fees to Tempus. The agreement with AstraZeneca expands on the strategic partnership between the two companies announced ...